Results 211 to 220 of about 9,118,901 (248)
Some of the next articles are maybe not open access.

Graft-versus-host disease and immunosuppression

Immunologic Research, 2008
In the last four decades, allogeneic hematopoietic stem cell transplant (HSCT) has been established as a curative therapy for many otherwise fatal diseases. Since 1968, from the time of the first successful allogeneic bone marrow transplant in a child with severe combined immune deficiency disease [1], tremendous progress has been made in this field of
openaire   +2 more sources

Enterococcus in Graft-versus-Host Disease

New England Journal of Medicine, 2020
Susceptibility to Graft-versus-Host-Disease A major cause of poor outcome after allogeneic hematopoietic-cell transplantation is graft-versus-host disease.
openaire   +2 more sources

Predicting graft-versus-host disease

Current Opinion in Immunology, 1995
Graft-versus-host disease (GVHD) is a serious complication that occurs after allogeneic bone marrow transplantation and contributes to transplant-related morbidity and mortality. Recent advances in the measurement of recipient-specific alloreactivity before marrow grafting have led to the development of in vitro assays that sufficiently predict the ...
openaire   +2 more sources

Graft-versus-Host Disease

New England Journal of Medicine, 1979
E D, Thomas, A, Fefer
openaire   +2 more sources

Graft-Versus-Host Disease: Implications

1993
The intent of the preparative regimen for bone marrow transplantation (BMT) is the destruction of the host tumor cell and the complete ablation of the host lymphohematopoietic system (Thomas 1983). Most aggressive conditioning regimens are applied, usually combining chemo- and radiotherapy, the latter in the form of total body irradiation.
openaire   +2 more sources

Graft Versus Host Disease

International Journal of Dermatology, 1982
openaire   +2 more sources

Graft‐versus‐host disease of the tongue

Otolaryngology–Head and Neck Surgery, 2009
Jeffrey D, Suh   +2 more
openaire   +2 more sources

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-Versus-Host Disease

New England Journal of Medicine, 2021
Nicola Polverelli   +2 more
exaly  

Home - About - Disclaimer - Privacy